ASHFORD CAPITAL MANAGEMENT INC
Q3 2026 Form 13-F

WILMINGTON, DELAWARE
CIK 0000897070 · CRD 110696 · SEC-registered investment adviser
$924.6M Reported Value Total

ASHFORD CAPITAL MANAGEMENT INC reports 95 total accounts under management (AUM). There are 95 discretionary accounts valued at $965,833,061, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
4 funds · $219.2M gross asset value
Hedge Fund: $219.2M
Source: Form ADV filed 2026-07-28
Reported value
$924.6M
Quarter over quarter
-0.3%
Holdings
105
Top-10 concentration
37.2%

Key People

Form ADV owners & control persons
Theodore H. Ashford III
CHIEF EXECUTIVE OFFICER, DIRECTOR, CHIEF INVESTMENT OFFICER (CLASS A&B SHARES)
Theodore H Ashford
CHAIRMAN, DIRECTOR (CLASS A SHARES)
Louise Victoria Horan
VICE PRESIDENT, OPERATIONS (CLASS B SHARES)

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2026 13F record

Q3 2026 13F filing summary

Q3 2026 Form 13F portfolio summary
Period of report September 30, 2026
Filed November 13, 2026
Form 13F-HR
Reported value $924.6M
Positions 105
Change in reported value -0.9%
New positions 6
Exited positions 8
Position turnover 12.4%
Top-10 concentration 37.2%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 13, 2026
105 $924.6M
Q2 2026 13F
Filed Aug 21, 2026
107 $932.6M
Q1 2026 13F
Filed May 15, 2026
99 $809.2M
Q4 2025 13F
Filed Feb 17, 2026
109 $897.7M
Q3 2025 13F
Filed Nov 14, 2025
110 $897.8M
Q2 2025 13F
Filed Aug 18, 2025
102 $851.1M
Q1 2025 13F
Filed May 15, 2025
99 $775.5M
Q4 2024 13F
Filed Feb 18, 2025
101 $847.6M
Q3 2024 13F
Filed Nov 18, 2024
102 $801.3M
Q2 2024 13F
Filed Aug 15, 2024
97 $740.6M
Q1 2024 13F
Filed May 15, 2024
91 $739.3M
Q4 2023 13F
Filed Feb 15, 2024
93 $746.4M
Q3 2023 13F
Filed Nov 15, 2023
91 $679.3M
Q2 2023 13F
Filed Aug 14, 2023
90 $715.5M
Q1 2023 13F
Filed May 15, 2023
90 $668.0M
Q4 2022 13F
Filed Feb 15, 2023
90 $644.9M
Q3 2022 13F
Filed Nov 16, 2022
92 $655.6M
Q2 2022 13F
Filed Aug 15, 2022
92 $703.7M
Q1 2022 13F
Filed May 16, 2022
101 $928.5M
Q4 2021 13F
Filed Feb 15, 2022
107 $1.0B

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2026

Largest Q3 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 LGND LIGAND PHARMACEUTICALS - CL B $52.0M 5.62%
2 RDVT RED VIOLET INC $46.1M 4.99%
3 GSAT GLOBALSTAR INC. $40.1M 4.33%
4 QMCO QUANTUM CORPORATION $38.8M 4.2%
5 VTI VANGUARD TOTAL STOCK MARKET ETF $38.4M 4.16%
6 UFPT UFP TECHNOLOGIES, INC. $29.9M 3.24%
7 SUPN SUPERNUS PHARMACEUTICALS INC. $26.6M 2.87%
8 SNEX STONEX GROUP, INC. $26.3M 2.85%
9 IDCC INTERDIGITAL INC. $23.7M 2.56%
10 EQIX EQUINIX INC $22.3M 2.41%
11 HQY HEALTHEQUITY, INC. $22.2M 2.4%
12 AYI ACUITY, INC. $21.9M 2.37%
13 INCY INCYTE CORP $21.8M 2.36%
14 LB LANDBRIDGE COMPANY, LLC $21.3M 2.31%
15 FROG JFROG LTD $20.7M 2.24%
16 VICR VICOR CORP $20.2M 2.18%
17 YOU CLEAR SECURE, INC. -CLASS A $19.6M 2.12%
18 SKWD SKYWARD SPECIALTY INSURANCE GROUP $19.1M 2.07%
19 FNV FRANCO-NEVADA CORP $18.2M 1.97%
20 VNOM VIPER ENERGY, INC. $17.9M 1.94%

Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings